Dispensing while impaired

Posted by john on November 28th, 2006 — in Nexium Top News

A pharmacist who’s tired and hungry might make a mistake that could kill you. But tired and hungry pharmacists have been a possibility in North Carolina since at least 1998, when politically appointed non-pharmacists blocked the N.C. Board of Pharmacy from setting work rules aimed at protecting the public.
Now the N.C. Supreme Court has kicked […]

Holiday Season Could Ring In ‘Heartburn Season’

Posted by john on November 24th, 2006 — in Nexium Top News

Main Category: GastroIntestinal / Gastroentorology News
Article Date: 21 Nov 2006 - 20:00pm (PST)
| email this article | printer friendly | view or write opinions |
sign up to our weekly newsletter Sign up for news alerts
Useful Article?
* Digg It
* Del.icio.us
* NewsVine
[…]

That warm, Thanksgiving feeling? Heartburn

Posted by john on November 23rd, 2006 — in Nexium Top News

Or maybe with a cold turkey snack before bed.
If heartburn were to choose a time to rear its big, burning head, today would be the day.
“After Thanksgiving, people are rubbing their tummies and groaning on the couch,” said Dr. Kurt Barrett, a family-practice physician in Athens who has written a book about gastroesophageal reflux disease.
Thanksgiving […]

U.S. FDA approves Nexium for treatment of Zollinger-Ellison Syndrome

Posted by john on November 14th, 2006 — in Nexium Top News

AstraZeneca (AZN) announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for the prescription proton pump inhibitor Nexium (esomeprazole magnesium) for the treatment of Zollinger-Ellison Syndrome (ZES).
Nexium already is indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children ages 12 to 17, and to reduce the […]

U.S. FDA approves Nexium for treatment of Zollinger-Ellison Syndrome

Posted by john on November 10th, 2006 — in Nexium Top News

AstraZeneca (AZN) announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for the prescription proton pump inhibitor Nexium (esomeprazole magnesium) for the treatment of Zollinger-Ellison Syndrome (ZES).
Nexium already is indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children ages 12 to 17, and to reduce the […]

Citigroup Cuts AstraZeneca Target; Still Hold

Posted by john on November 1st, 2006 — in Nexium Top News

0951 GMT [Dow Jones] Citigroup cuts AstraZeneca’s (AZN.ISE) price target to US$65 from US$68 but maintains its hold rating.
Drugs Online - Buy Drugs Online at reasanoble prices.DrugOnline.cc provides confortable and easy way to order drugs online including drugs free shipping.
It believes the shares are oversold since its 3Q results, but says there is no […]